US BROKER MOVES: RIOT upgraded at Jefferies; DKNG downgraded at Berenberg

• Magnolia Oil & Gas (MGY) Upgraded from Neutral to Buy at Gerdes Energy Research; PT USD 29
• Morgan Stanley Direct Lending Fund (MSDL) Upgraded from Neutral to Buy at UBS; PT USD 14.50
• Cloudflare (NET) Upgraded from Sell to Buy at DZ Bank; PT USD 300
• Orion (OEC) Upgraded from Underweight to Neutral at JPMorgan
• Riot Platforms (RIOT) Upgraded from Hold to Buy at Jefferies; PT USD 28
• Southern Copper (SCCO) Upgraded from Sell to Neutral at UBS; PT USD 180
• Securitize (SECZ) Upgraded from Neutral to Buy at Citi; PT USD 14
• Senseonics (SENS) Upgraded from Underperform to Market Perform at Raymond James
• Sarepta Therapeutics (SRPT) Upgraded from Sell to Hold at Deutsche Bank; PT USD 18
• Zentalis Pharmaceuticals (ZNTL) Upgraded from Neutral to Outperform at Wedbush; PT USD 6

• Academy Sports and Outdoors (ASO) Downgraded from Buy to Hold at Loop Capital
• Peabody Energy (BTU) Downgraded from Buy to Hold at Jefferies; PT USD 18
• Carlyle Group (CG) Downgraded from Buy to Neutral at UBS; PT USD 47
• DraftKings (DKNG) Downgraded from Buy to Hold at Berenberg; PT USD 20
• EVgo (EVGO) Downgraded from Outperform to Sector Perform at RBC Capital; PT USD 2
• EVgo (EVGO) Downgraded from Buy to Neutral at Roth/MKM; PT USD 2
• Trex (TREX) Downgraded from Buy to Neutral at DA Davidson
• Vistance Networks (VISN) Downgraded from Outperform to Market Perform at Northland; PT USD 4
• Wix.com (WIX) Downgraded from Buy to Underperform at BofA Securities; PT USD 68

• Alvotech (ALVO) Initiated at Buy at Jefferies; PT USD 9
• American Public Education (APEI) Initiated at Buy at DA Davidson
• City Therapeutics (CTY) Initiated at Early-Stage Biotech at Goldman Sachs
• City Therapeutics (CTY) Initiated at Buy at Jefferies; PT USD 32
• City Therapeutics (CTY) Initiated at Outperform at Oppenheimer; PT USD 46
• City Therapeutics (CTY) Initiated at Buy at Stifel; PT USD 34
• Viant Technology (DSP) Initiated at Buy at DA Davidson
• EMCOR Group (EME) Initiated at Neutral at JPMorgan; PT USD 700
• East West Bancorp (EWBC) Initiated at Outperform at Hovde Group; PT USD 153
• Comfort Systems USA (FIX) Initiated at Overweight at JPMorgan; PT USD 1,700
• Iambic Therapeutics (IAM) Initiated at Buy at Jefferies; PT USD 35
• MongoDB (MDB) Initiated at Buy at BTIG; PT USD 417
• Mentari Therapeutics (MTRI) Initiated at Buy at Jefferies; PT USD 30
• Mentari Therapeutics (MTRI) Initiated at Buy at Stifel; PT USD 30
• ONEOK (OKE) Initiated at Equalweight at Barclays; PT USD 94
• Palantir (PLTR) Initiated at Buy at Fubon; PT USD 200
• Philip Morris International (PM) Initiated at Neutral at JPMorgan; PT USD 200
• Sterling Infrastructure (STRL) Initiated at Overweight at JPMorgan; PT USD 585
• The Trade Desk (TTD) Initiated at Neutral at DA Davidson

Daily broker roundups of this kind are a standing feature of the US tape and historically move only the named single stocks, and even there the reaction is usually strongest where the rating crosses a full spectrum, Sell to Buy or Buy to Underperform, rather than a one-notch shift, since those imply a genuine change of thesis rather than model maintenance. On that read the items most likely to register are the double-jump calls and the outright sell-side departures, while Neutral-to-Buy moves at smaller research houses tend to fade within the session absent a fresh thesis note. Two structural features stand out in this list: a paired coal divergence, with one major house upgrading a miner while another cuts a peer, a pattern that in past episodes has signalled disagreement on the underlying commodity deck rather than company specifics, and a heavy cluster of initiations on a single early-stage biotech across multiple banks, which is the standard shape of a recent listing or financing being brought under coverage and typically produces a mechanical volume and volatility bump in the name regardless of direction. The initiation-heavy skew toward healthcare and industrial names, and the downgrades concentrated in consumer and digital-gaming discretionary, is the kind of cross-sector tilt that has preceded sector-relative flows when it repeats over consecutive sessions rather than appearing as a one-day artifact. The follow-ons worth noting are whether any of the price-target changes are followed by estimate revisions, which is what historically separates a durable repricing from a headline-driven gap, and whether peers of the downgraded names get sympathy moves, the usual tell that the market reads the call as sector-level rather than idiosyncratic. As a roundup rather than a single high-conviction call, the signal content is diffuse.